highly significantP < 0.001
Additionally, 46.57% of patients in the PV group were HBeAg-positive, compared to 21.30% in the CVR group, a highly significant difference (P < 0.001).
Additionally, 46.57% of patients in the PV group were HBeAg-positive, compared to 21.30% in the CVR group, a highly significant difference (P < 0.001).